Clinical Trial Update: A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

This clinical trial update indicates that NSI-8226 is being studied for efficacy and safety in adults with eosinophilic esophagitis in Phase 2, and the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• NSI-8226 (NSI-8226)

Snippet

Sponsor: Uniquity One (UNI) | Conditions: Eosinophilic Esophagitis (EoE) | Phase 2 | Status: ACTIVE_NOT_RECRUITING